Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Open-Label Study of PQR309 in Relapsed or Refractory Lymphoma
2014-005384-33Phase 2Completed
- Sponsor
- PIQUR Therapeutics AG
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bimiralisib in lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by PIQUR Therapeutics AG. Started Jun 2015; status: completed.
02
Drugs
bimiralisib
03
Conditions
lymphomachronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2014-005384-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005384-33.